Barclays lowered the firm’s price target on Cigna (CI) to $354 from $385 and keeps an Overweight rating on the shares following the Q2 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna Group Reports Strong Q2 2025 Earnings
- Cigna’s Earnings Call: Strong Results Amid Challenges
- Wells Fargo surprised to see Cigna stock weaker following pullback
- Morning Movers: Roblox skyrockets following second quarter results
- Cigna backs FY25 adjusted EPS view at least $29.60, consensus $29.69